Publicité
Novara — A Smarter Way to Access Global Markets
Desk marchés·mis à jour au fil de la journée

Actions

GLP-1 weight-loss drugs fuel biotech and food sector growth
ActionsArticle

GLP-1 weight-loss drugs fuel biotech and food sector growth

Semaglutid-based therapies drive expansion in pharmaceuticals and food innovation as companies target the $100 billion obesity treatment market.

Rédaction Marchés · 19 Aug 2026
HSBC upgrades South Korea to overweight on easing deleveraging risks
ActionsArticle

HSBC upgrades South Korea to overweight on easing deleveraging risks

HSBC shifts Korean equities to overweight as margin debt falls $21 billion and leveraged ETF assets shrink. Analyst cites strong earnings outlook through 2027, including a potential 7% dividend yield at Samsung Electronics.

Rédaction Marchés · 19 Aug 2026
Volkswagen seeks India partner deal by year-end, Skoda CEO says
ActionsArticle

Volkswagen seeks India partner deal by year-end, Skoda CEO says

German automaker targets local joint venture to expand in India’s fast-growing car market amid regulatory challenges and emissions rules. Skoda CEO cites need for deeper local roots.

Rédaction Marchés · 19 Aug 2026
Nordic Mining shares slide 6.3% as liquidity crunch hits Engebø ramp-up
ActionsArticle

Nordic Mining shares slide 6.3% as liquidity crunch hits Engebø ramp-up

The Oslo-listed miner’s stock extended losses after second-quarter results showed a NOK 154.3 million operating loss and no revenue amid production delays at its flagship Engebø project.

Rédaction Marchés · 19 Aug 2026
Finland’s OMX Helsinki 25 falls 1.61% as Nokia, Metso weigh on market
ActionsArticle

Finland’s OMX Helsinki 25 falls 1.61% as Nokia, Metso weigh on market

Telecoms, industrials and technology led declines on the Helsinki exchange. Nokia dropped 7.29% while Metso fell 4.71% as broader benchmark slid.

Rédaction Marchés · 19 Aug 2026
Halyk Bank posts 15% profit drop in H1 2026 as margins tighten
ActionsArticle

Halyk Bank posts 15% profit drop in H1 2026 as margins tighten

Kazakh lender reports KZT 447.6 billion net income, cites rising credit costs and regulatory pressures. Digital adoption accelerates despite margin squeeze.

Rédaction Marchés · 19 Aug 2026
Swiss stocks edge up as Roche, Novartis lead; ABB, Amrize weigh
ActionsArticle

Swiss stocks edge up as Roche, Novartis lead; ABB, Amrize weigh

The SMI rose 0.13% to 14,321 points, with healthcare heavyweights Roche and Novartis offsetting losses in ABB and Amrize. Global bond yields surged to multi-year highs, unsettling investors.

Rédaction Marchés · 19 Aug 2026
US stocks mixed pre-market; Moderna surges 72% on Merck trial data
ActionsArticle

US stocks mixed pre-market; Moderna surges 72% on Merck trial data

SMI edges higher as Moderna jumps on positive melanoma trial results with Merck’s Keytruda. Geberit, Implenia lead Swiss gains; DocMorris, Straumann lag. Brent crude hits $92 amid Iran conflict.

Rédaction Marchés · 19 Aug 2026
UGI shares surge 14% on KKR takeover report
ActionsArticle

UGI shares surge 14% on KKR takeover report

Private equity giant KKR reportedly offers $9 billion for UGI Corporation at $42.50 per share, lifting the utility distributor's stock nearly 20% above its pre-announcement level.

Rédaction Marchés · 19 Aug 2026
US stocks rise as Moderna surges 150% on cancer vaccine data
ActionsArticle

US stocks rise as Moderna surges 150% on cancer vaccine data

Moderna’s mRNA cancer vaccine trial results drive a 150% jump in its shares, lifting the S&P 500 and Swiss pharma stocks. US net interest payments hit a record 3.3% of GDP.

Rédaction Marchés · 19 Aug 2026
Nasdaq slips as Moderna surges; US net interest payments hit record high
ActionsArticle

Nasdaq slips as Moderna surges; US net interest payments hit record high

Moderna’s 72% rally fuels gains in biotech and Swiss pharma shares, while U.S. net interest costs rise to 3.3% of GDP—the highest on record. SMI edges higher as defensive stocks offset semiconductor weakness.

Rédaction Marchés · 19 Aug 2026
Basilea Pharmaceutica posts 32% profit surge in H1 2026, raises guidance
ActionsArticle

Basilea Pharmaceutica posts 32% profit surge in H1 2026, raises guidance

Swiss drugmaker reports CHF 27.9 million net profit for the first half, driven by strong Cresemba sales and non-dilutive funding. Full-year outlook upgraded on revenue and profit growth.

Rédaction Marchés · 19 Aug 2026
US stocks rise as Moderna surges; US net interest costs hit record high
ActionsArticle

US stocks rise as Moderna surges; US net interest costs hit record high

Moderna’s 118% rally lifts biotech and Swiss pharma; Dow, S&P 500 and Nasdaq 100 advance. US net interest payments climb to 3.3% of GDP, highest on record.

Rédaction Marchés · 19 Aug 2026
Basilea raises 2026 revenue, profit forecasts after strong H1 results
ActionsArticle

Basilea raises 2026 revenue, profit forecasts after strong H1 results

Swiss drugmaker posts CHF 119 million in H1 revenue, a 14% rise, and doubles full-year profit guidance as Cresemba and Zevtera sales accelerate.

Rédaction Marchés · 19 Aug 2026
JDC posts record H1 2026 profit, eyes AVD launch in 2027
ActionsArticle

JDC posts record H1 2026 profit, eyes AVD launch in 2027

First-half revenue rose 18.7% to €143.5 million as AI-driven efficiency gains offset weak contract transfers. Altersvorsorgedepot platform to target 50 million eligible Germans from January.

Rédaction Marchés · 19 Aug 2026
Conduit Holdings names Mark Pickering as new CFO, effective Nov 2026
ActionsArticle

Conduit Holdings names Mark Pickering as new CFO, effective Nov 2026

Pickering, former Aspen Insurance CFO, will replace Elaine Whelan and join the board. His appointment follows Aspen’s IPO and acquisition by Sompo earlier this year.

Rédaction Marchés · 19 Aug 2026
Klarna shares plunge 22% after profit warning, forecast cut
ActionsArticle

Klarna shares plunge 22% after profit warning, forecast cut

Swedish fintech’s U.S.-listed stock fell sharply after it lowered annual revenue guidance and cited weak performance in its largest market, Germany. CFO and CMO roles to be refilled in 2027.

Rédaction Marchés · 19 Aug 2026
Shaires Holdings delays retail share offer deadline to Aug 24
ActionsArticle

Shaires Holdings delays retail share offer deadline to Aug 24

London-based investment firm extends closing date for $20 share offer to Aug 24, 2026, at 4:30 pm, maintaining trading pause until further notice.

Rédaction Marchés · 19 Aug 2026
TD Cowen flags unresolved questions ahead of Nvidia, Broadcom earnings
ActionsArticle

TD Cowen flags unresolved questions ahead of Nvidia, Broadcom earnings

Analysts remain neutral on Nvidia and Broadcom despite raised long-term datacenter market estimates, citing unresolved debates over roadmaps and margins.

Rédaction Marchés · 19 Aug 2026
Six small-cap energy stocks trading below 7x P/E with 29% average upside
ActionsArticle

Six small-cap energy stocks trading below 7x P/E with 29% average upside

StealthGas, SandRidge Energy and four others show strong free cash flow yields and minimal leverage amid elevated energy prices. Analyst coverage remains sparse for most names.

Rédaction Marchés · 19 Aug 2026
S&P affirms Nvidia's AA rating, cites Ohio AI campus guarantee
ActionsArticle

S&P affirms Nvidia's AA rating, cites Ohio AI campus guarantee

Credit agency S&P Global Ratings maintains Nvidia's AA issuer credit rating with a stable outlook, citing a $105 billion guarantee tied to an Ohio AI data center campus. The rating agency also adjusted future debt projections based on the facility's development schedule.

Rédaction Marchés · 19 Aug 2026
Basilea Pharmaceutica lifts H1 2026 outlook as stock surges 8.7%
ActionsArticle

Basilea Pharmaceutica lifts H1 2026 outlook as stock surges 8.7%

Swiss biotech raised its full-year revenue and profit guidance after reporting a 14% revenue jump in H1 2026. Shares rose 8.7% in pre-market trading.

Rédaction Marchés · 19 Aug 2026
Global stocks slip as yields surge; Swiss market edges up on pharma gains
ActionsArticle

Global stocks slip as yields surge; Swiss market edges up on pharma gains

Nasdaq leads losses as U.S. 30-year yields hit 19-year high. SMI ekes out gains on Roche, Novartis gains; ABB falls. Brent crude near $91, gold dips.

Rédaction Marchés · 19 Aug 2026
EVS posts record H1 2026 revenue as stock remains flat
ActionsArticle

EVS posts record H1 2026 revenue as stock remains flat

Broadcast equipment firm EVS reported a 70% year-over-year rise in adjusted H1 revenue to EUR 107.2 million, while net profit grew 24% to EUR 16.5 million. Full-year 2026 revenue guidance was set at EUR 220-240 million.

Rédaction Marchés · 19 Aug 2026